1Plucky J.Inflammatoryy pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol, 2001, 88(Suppl) : 10K.
2Mazzone A, DeServi S, Ve:Ddi M, et al.Plasma levels of interleukin2, 6,10 and phenotypic characterization of circulating T lymphocytes in ischenicheart disease. Atherosclerosis, 1999, 145(2):369.
3Parmtteru G, Marino B, Campa PP, et al. Interleukins 6 and 8 as mediators of acute phase response in acute myocardial infarction. Am J Cardioi, 1997,80:622.
4Koukkunen H, Penttila K, Kemppainen A, et al. C- reactive protein, fibrinogen, interleukin - 6 and tumour necrosis factor - alpha in the prognostic classification of unstable angina pectoris. Ann Med, 2001, 33(1):37.
5Biasucci LM, Liuzzo G, Fantuzzi G, et al. Increasin levels of intedeukin(IL) - 1Ra and IL - 6 during the first 2 days of hospitalization in unstable arugina are associated with increased risk of in - hospital coronary events. Circulation, 1999, 99:2079.
6Deliargyris EN, Raymond Pd, Theoharides TC, et al. Sites of interleukin- 6 release in patients with acute coronary syndromes and in pafieats with congestive heart failure. Am J Cardiol, 2000, 86(9):913.
7Ikeda U, Ito T, Shimada K. Intedeukin - 6 and acute coronary syndrome.Clin Caidiol, 2001, 24(11):701.
8Bickel C, Rupprecht HJ, Blankenberg S, et al. Non- lipid lowering effects statin medication in patients with coronary heart disease. J Am Coil Catdiol, 2000, 35: 256A.
9Marczin N, Antonov A, Papapetropoulos A, et al.Monocyte-induced downregulation of nitric oxide synthase in cultured aortic endothelial cells. Arterioscler Thromb Vasc Biol, 1996, 16:1095.
10Guillen 1, Blanes M, Gomez- Lechon MJ, et al. Cytokine signaling during myocardial infarction: sequential appearance of IL - B and IL - 6. Am J Physid, 1995, 266: R229.
